| Uric acid and hypertension: an update with recommendations LG Sanchez-Lozada, B Rodriguez-Iturbe, EE Kelley, T Nakagawa, ... American journal of hypertension 33 (7), 583-594, 2020 | 145 | 2020 |
| Case series: CTLA4-IgG1 therapy in minimal change disease and focal segmental glomerulosclerosis EH Garin, J Reiser, G Cara-Fuentes, C Wei, D Matar, H Wang, N Alachkar, ... Pediatric Nephrology 30, 469-477, 2015 | 102 | 2015 |
| CD80 and suPAR in patients with minimal change disease and focal segmental glomerulosclerosis: diagnostic and pathogenic significance G Cara-Fuentes, C Wei, A Segarra, T Ishimoto, C Rivard, RJ Johnson, ... Pediatric Nephrology 29, 1363-1371, 2014 | 86 | 2014 |
| C4 nephritic factors in C3 glomerulopathy: a case series Y Zhang, NC Meyer, FC Fervenza, W Lau, A Keenan, G Cara-Fuentes, ... American journal of kidney diseases 70 (6), 834-843, 2017 | 58 | 2017 |
| Serum from minimal change patients in relapse increases CD80 expression in cultured podocytes T Ishimoto, G Cara-Fuentes, H Wang, M Shimada, CH Wasserfall, ... Pediatric Nephrology 28, 1803-1812, 2013 | 56 | 2013 |
| Minimal change disease: a dysregulation of the podocyte CD80–CTLA-4 axis? G Cara-Fuentes, CH Wasserfall, H Wang, RJ Johnson, EH Garin Pediatric Nephrology 29, 2333-2340, 2014 | 55 | 2014 |
| Nephrin is necessary for podocyte recovery following injury in an adult mature glomerulus R Verma, M Venkatareddy, A Kalinowski, T Li, J Kukla, A Mollin, ... PLoS One 13 (6), e0198013, 2018 | 51 | 2018 |
| Pathogenesis of proteinuria in idiopathic minimal change disease: molecular mechanisms G Cara-Fuentes, WL Clapp, RJ Johnson, EH Garin Pediatric nephrology 31, 2179-2189, 2016 | 49 | 2016 |
| Long-term outcome of focal segmental glomerulosclerosis after pediatric renal transplantation. TMN Fuentes GM, Meseguer CG, Carrion AP, Hijosa MM, Garcia-Pose A, Melgar AA Pediatr Nephrol 25 (3), 529-534, 2010 | 39 | 2010 |
| Angiopoietin-like-4 and minimal change disease G Cara-Fuentes, A Segarra, C Silva-Sanchez, H Wang, MA Lanaspa, ... PLoS One 12 (4), e0176198, 2017 | 27 | 2017 |
| Hyperuricemia and chronic kidney disease: to treat or not to treat F Piani, F Sasai, P Bjornstad, C Borghi, A Yoshimura, ... Brazilian Journal of Nephrology 43, 572-579, 2021 | 25 | 2021 |
| The RIVUR study: a review of its findings G Cara-Fuentes, N Gupta, EH Garin Pediatric Nephrology 30, 703-706, 2015 | 25 | 2015 |
| Long-term use of continuous subcutaneous insulin infusion compared with multiple daily injections of glargine in pediatric patients BA García-García E, Galera R, Aguilera P, Cara G J Pediatr Endocrinol Metab 20 (1), 37-40, 2007 | 25 | 2007 |
| Expression of human CD47 in pig glomeruli prevents proteinuria and prolongs graft survival following pig‐to‐baboon xenotransplantation K Takeuchi, Y Ariyoshi, A Shimizu, Y Okumura, G Cara‐Fuentes, ... Xenotransplantation 28 (6), e12708, 2021 | 23 | 2021 |
| Abatacept in steroid-dependent minimal change disease and CD80-uria R Isom, S Shoor, J Higgins, G Cara-Fuentes, RJ Johnson Kidney international reports 4 (9), 1349-1353, 2019 | 19 | 2019 |
| Glomerular endothelial cells and podocytes can express CD80 in patients with minimal change disease during relapse G Cara-Fuentes, M Venkatareddy, R Verma, A Segarra, AC Cleuren, ... Pediatric Nephrology 35, 1887-1896, 2020 | 18 | 2020 |
| Rituximab in idiopathic nephrotic syndrome: does it make sense? G Cara-Fuentes, JA Kairalla, T Ishimoto, C Rivard, RJ Johnson, EH Garin Pediatric Nephrology 29, 1313-1319, 2014 | 18 | 2014 |
| Molecular mechanisms of proteinuria in minimal change disease S Purohit, F Piani, FA Ordoñez, C de Lucas-Collantes, C Bauer, ... Frontiers in Medicine 8, 761600, 2021 | 17 | 2021 |
| CD80, suPAR and nephrotic syndrome in a case of NPHS2 mutation G Cara-Fuentes, C Araya, C Wei, C Rivard, T Ishimoto, J Reiser, ... Nefrología (English Edition) 33 (5), 727-731, 2013 | 16 | 2013 |
| Minimal change disease is associated with endothelial glycocalyx degradation and endothelial activation C Bauer, F Piani, M Banks, FA Ordoñez, C de Lucas-Collantes, K Oshima, ... Kidney international reports 7 (4), 797-809, 2022 | 15 | 2022 |
